Zika virus NSI antigen and application of Zika virus NSI antigen in preparing fluorescence immunochromatographic reagent
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHINESE ACAD OF INSPECTION & QUARANTINE
- Publication Date
- 2019-12-13
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a method for detecting Zika virus NS1 antigen and its application in the preparation of fluorescent immunochromatography reagents, belonging to the technical field of fluorescent immune chromatography in medical immunology. Background technique
[0002] After people are infected with Zika virus (Zika Virus), 1 / 4-1 / 5 of the infected people will develop the disease. The clinical features are mild and mostly flu-like, mainly fever, arthralgia, rash or conjunctivitis, which lasts for several days. However, some patients will develop Guillain-Barré syndrome, which poses a great threat to pregnant women, leading to fetal miscarriage, neonatal microcephaly and even death. Zika virus disease urgently needs prevention and control.
[0003] After Zika virus infection, its symptoms are mild, and about 80% of Zika virus-infected patients will not show any symptoms, which has greatly interfered with clinical diagnosis and the prevention an...